APRE Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-08-13SCHEDULE 13G/A0000935836-26-000399SEC →
2026-08-1210-Q0001104659-26-094544SEC →
2026-08-128-K0001104659-26-094542SEC →
2026-07-238-K0001104659-26-086254SEC →
2026-06-1740001104659-26-075286SEC →
2026-06-1740001104659-26-075284SEC →
2026-06-1740001104659-26-075283SEC →
2026-06-1740001104659-26-075282SEC →
2026-06-1740001104659-26-075281SEC →
2026-06-1740001104659-26-075280SEC →
2026-06-1740001104659-26-075279SEC →
2026-06-1740001104659-26-075278SEC →
2026-06-178-K0001104659-26-075151SEC →
2026-05-15424B70001104659-26-062631SEC →
2026-05-15SCHEDULE 13G0000902664-26-002544SEC →
2026-05-1310-Q0001104659-26-059743SEC →
2026-05-138-K0001104659-26-059734SEC →
2026-04-30ARS0001104659-26-052063SEC →
2026-04-30DEFA14A0001104659-26-052049SEC →
2026-04-30DEF 14A0001104659-26-052044SEC →
2026-04-29EFFECT9999999995-26-001389SEC →
2026-04-29424B30001104659-26-051739SEC →
2026-04-27SCHEDULE 13G/A0001493152-26-019073SEC →
2026-04-27CORRESP0001104659-26-049298SEC →
2026-04-27UPLOAD0000000000-26-004268SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
Aprea Therapeutics (APRE) — Filings